Media Tip Sheet: Story Suggestions For World Aids Day Monday,
December 1
PR Newswire - November 25, 1997 10:55
As you plan coverage and editorial in recognition of World Aids Day, next Monday, December 1, INFOCUS urges you to consider the information below for inclusion in your stories.
This information is important to the fight against AIDS because it relates to women's health and preventing the transmission of HIV, and a nationwide network of reduced-fee healthcare services available to anyone -- regardless of pre-existing medical conditions.
-- National Health & Safety Corporation (NHS),
(OTC Bulletin Board: NHLT) headquartered in Warminster, Pennsylvania, is launching POWERx Access, a nationwide network of healthcare practitioners who provide reduced-fee medical care and products, in January 1998. NHS' POWERx Access network includes almost 60 percent of all U.S. doctors, hospitals, and surgeons, and more than 90 percent of pharmacies. For just $17 a month, participants in the POWERx Access Medical Benefits Network also have reduced-fee access to dentists, orthodontists, home nursing care, radiology, clinical lab services, psychiatrists, psychologists, chiropractors, vision and
hearing care, and other providers of medical supplies and services. Providers offer fixed fees discounted by up to 50 percent. POWERx Access is available to everyone, regardless of age, occupation, or pre-existing medical conditions.
-- Procept, Inc. (Nasdaq: PRCT), based in Cambridge, Massachusetts, is developing a topical microbicide gel to provide women with the ability to protect themselves against HIV and other sexually transmitted diseases (STDs). Designed to be odorless, tasteless and relatively inexpensive, the gel offers a female-controlled method for preventing HIV infection without the need to negotiate protection, such as they would with the use of a condom. When the gel is applied intravaginally, the patented compound, PRO 2000, prevents initial infection of cells by HIV. PRO 2000 works by forming an "invisible"
chemical barrier, which blocks entry of HIV and other viruses into CD4
receptors. In May of 1997, researchers discovered that raising the
concentration levels of the PRO 2000 compound allows the product to function as a contraceptive, increasing the possible applications of the gel.
CONTACT: Karen Goldman or Geri Rosman of INFOCUS, 609-683-9055, ext. 147, for National Health & Safety and Procept. |
